Daniel O'Day

Chairman and CEO, Gilead Sciences

Foster City, California

About

Daniel O'Day is chairman and chief executive officer of Gilead Sciences, a biopharmaceutical company based in Foster City, California, that develops medicines for HIV, liver disease, cancer and other conditions. He joined Gilead in March 2019 in both roles. Before that he spent about three decades at Roche, where he was CEO of Roche Pharmaceuticals.

O'Day holds a bachelor's degree in biology from Georgetown University and an MBA from Columbia University. At Roche he held executive positions in the pharmaceutical and diagnostics divisions in North America, Europe and Asia and sat on the Roche Corporate Executive Committee. He serves on the boards of PhRMA and Georgetown University. Other pharmaceutical chiefs with pages on Whoo include David Ricks of Eli Lilly, Robert Bradway of Amgen and Chris Boerner of Bristol Myers Squibb.

Whoo compiled this page from public sources: Gilead leadership page, Gilead third quarter 2026 results, UC Berkeley Haas newsroom. It is not affiliated with or endorsed by Daniel O'Day. Are you Daniel O'Day? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-17.

Want a page like this? Create yours from your résumé.

Experience

Chairman and Chief Executive Officer — Gilead Sciences


March 2019 – Present

  • Leads the company in both roles
  • CEO, Roche Pharmaceuticals — Roche

  • Served on Roche's Corporate Executive Committee
  • Executive roles — Roche

  • Held executive positions in pharmaceutical and diagnostics divisions in North America, Europe and Asia over about three decades

Education

Bachelor's degree in Biology — Georgetown University

MBA — Columbia University

Projects